High grade astrocytic tumor
MONDO:0016680An anaplastic astrocytoma (grade III astrocytic tumor) or glioblastoma (grade IV astrocytic tumor).
Also known as: high grade astrocytic neoplasm, high grade astrocytic tumor, high-grade astrocytic neoplasm, high-grade astrocytic tumor, high-grade astrocytic tumour, high-grade astrocytoma
3433 clinical trials for this condition and its sub-types, 8 tagged with High grade astrocytic tumor itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of High grade astrocytic tumor
-
Glioblastoma 638 trials · 651 incl. sub-types
7 sub-types
- Brain glioblastoma 24 trials · 87 incl. sub-types Sub-types →
- IDH-wildtype glioblastoma 83 trials
- Adult glioblastoma 25 trials Sub-types →
- Classical glioblastoma 3 trials
- Mesenchymal glioblastoma 0 trials
- Neural glioblastoma 0 trials
- Proneural glioblastoma 0 trials
-
Anaplastic astrocytoma 53 trials · 101 incl. sub-types
3 sub-types
- IDH-mutant anaplastic astrocytoma 10 trials · 49 incl. sub-types Sub-types →
- IDH-wildtype anaplastic astrocytoma 3 trials
- High-grade astrocytoma with piloid features 0 trials
-
Gliomatosis cerebri 1 trial
Most studied deeper sub-types
-
New drug combo shows promise for kids with aggressive brain tumors
Disease control OngoingThis phase 2 trial tests whether two targeted drugs, dabrafenib and trametinib, can improve outcomes for children and young adults with a specific type of high-grade glioma (BRAF V600-mutant) after they receive radiation therapy. The study enrolls 58 participants aged 25 or young…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a vaccine train Kids' bodies to fight brain cancer?
Disease control OngoingThis early-phase study tests a vaccine called SurVaxM in 35 children with certain brain tumors that have come back or are hard to treat. The vaccine is designed to teach the immune system to find and destroy tumor cells that have a protein called survivin. The goal is to see if i…
Phase 1 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC